Aviva PLC Exact Sciences Corp Transaction History

Aviva PLC

$28.3 Billion
Q1 2024

A detailed history of Aviva PLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Aviva PLC holds 6,840 shares of EXAS stock, worth $288,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,840

Previous 36,920 81.47%

Holding current value

$288,990

Previous $2.73 Million 82.72%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $1.69 Million - $2.22 Million	-30,080 Reduced 81.47%	6,840 $472,000
Q4 2023 Feb 09, 2024	SELL	$59.06 - $75.72 $4.14 Million - $5.31 Million	-70,134 Reduced 65.51%	36,920 $2.73 Million
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $5.6 Million - $8.41 Million	84,888 Added 382.96%	107,054 $7.3 Million
Q2 2023 Aug 10, 2023	BUY	$62.68 - $95.05 $135,890 - $206,068	2,168 Added 10.84%	22,166 $2.08 Million
Q1 2023 May 12, 2023	SELL	$47.19 - $70.77 $189,703 - $284,495	-4,020 Reduced 16.74%	19,998 $1.36 Million

Q4 2022 Feb 09, 2023	SELL	$30.35 - $53.15 $7,496 - $13,128	-247 Reduced 1.02%	24,018 $1.19 Million
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $960,155 - $1.48 Million	-30,033 Reduced 55.31%	24,265 $788,000
Q2 2022 Aug 04, 2022	SELL	$35.61 - $76.23 $50,993 - $109,161	-1,432 Reduced 2.57%	54,298 $2.14 Million
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $38,450 - $55,136	668 Added 1.21%	55,730 $3.9 Million
Q4 2021 Feb 10, 2022	BUY	$72.5 - $100.68 $200,317 - $278,178	2,763 Added 5.28%	55,062 $4.29 Million
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $238,775 - $328,236	-2,646 Reduced 4.82%	52,299 $4.99 Million
Q2 2021 Aug 10, 2021	BUY	$93.66 - $139.27 $530,864 - $789,382	5,668 Added 11.5%	54,945 $6.83 Million
Q1 2021 May 13, 2021	BUY	$116.57 - $155.01 $4,662 - $6,200	40 Added 0.08%	49,277 $6.49 Million
Q4 2020 Feb 10, 2021	BUY	$99.61 - $142.12 $116,244 - $165,854	1,167 Added 2.43%	49,237 $6.52 Million
Q3 2020 Nov 12, 2020	SELL	$72.92 - $102.01 $82,837 - $115,883	-1,136 Reduced 2.31%	48,070 $4.9 Million
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $2,062 - $3,431	-37 Reduced 0.08%	49,206 $4.28 Million
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $15,728 - $43,342	415 Added 0.85%	49,243 $2.86 Million
Q4 2019 Feb 10, 2020	BUY	$77.66 - $99.74 $416,801 - $535,304	5,367 Added 12.35%	48,828 $4.52 Million
Q3 2019 Nov 12, 2019	BUY	$90.37 - $122.49 $3.93 Million - $5.32 Million	43,461 New	43,461 $3.93 Million

Others Institutions Holding EXAS

# of Institutions

699

Shares Held

160M

Call Options Held

5.84M

Put Options Held

2.58M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.48B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account